Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research
Saved in:
| Title: | Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research |
|---|---|
| Authors: | Curi Bio |
| Source: | Business Wire (English). 08/22/2024. |
| Abstract: | Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, is proud to announce the signing of a seven-year lease for a 13,942-square-foot space at BioMed Realty’s 201 Elliott Avenue West in Seattle. This strategic expansion will enable Curi Bio to expand its research and development efforts, advancing its mission to unlock critical human data that informs biopharmaceutical R&D decision-making. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, is proud to announce the signing of a seven-year lease for a 13,942-square-foot space at BioMed Realty’s 201 Elliott Avenue West in Seattle. This strategic expansion will enable Curi Bio to expand its research and development efforts, advancing its mission to unlock critical human data that informs biopharmaceutical R&D decision-making. [ABSTRACT FROM PUBLISHER] |
|---|
